1-4 of 4
Pei-Jung Lin
Close
Sort by
Journal Articles

The Incidence and Cost of Hospice Use Among Elderly Patients with Diffuse Large B-Cell Lymphoma: A SEER-Medicare Analysis

Anita J Kumar, MD MS, Aaron Winn, MPP, Gunjan L Shah, MD MS, Pei-Jung Lin, PhD MS, Susan K Parsons, MD MRP
Journal: Blood
Blood (2016) 128 (22): 5951.
https://doi.org/10.1182/blood.V128.22.5951.5951
Published: 2016
Journal Articles

Comparison of Survival and Costs of Rituximab-Based Chemotherapy for Initial Therapy of Follicular Lymphoma in Elderly Patients

Gunjan L. Shah, MDMS, Aaron Winn, MPP, Pei-Jung Lin, PhDMS, Anita J Kumar, MDMS, Susan K Parsons, MDMRP
Journal: Blood
Blood (2016) 128 (22): 2354.
https://doi.org/10.1182/blood.V128.22.2354.2354
Published: 2016
Journal Articles

The Utility of the Charlson Comorbidity Index in Predicting Use of Treatment and Survival in Older Lymphoma Patients

Gunjan L. Shah, MD MS, Aaron Winn, MPP, Anita J Kumar, MD MS, Miguel-Angel Perales, MD, Pei-Jung Lin, Ph DMS, Susan K Parsons, MD MRP
Journal: Blood
Blood (2016) 128 (22): 2405.
https://doi.org/10.1182/blood.V128.22.2405.2405
Published: 2016
Journal Articles

Value of innovation in hematologic malignancies: a systematic review of published cost-effectiveness analyses

Clinical Trials & Observations
Cayla J. Saret, Aaron N. Winn, Gunjan Shah, Susan K. Parsons, Pei-Jung Lin, Joshua T. Cohen, Peter J. Neumann
Journal: Blood
Blood (2015) 125 (12): 1866–1869.
https://doi.org/10.1182/blood-2014-07-592832
Published: 2015
Includes: Supplemental data